226 related articles for article (PubMed ID: 21029471)
1. Executive functions and selective attention are favored in middle-aged healthy women carriers of the Val/Val genotype of the catechol-o-methyltransferase gene: a behavioral genetic study.
Solís-Ortiz S; Pérez-Luque E; Morado-Crespo L; Gutiérrez-Muñoz M
Behav Brain Funct; 2010 Oct; 6():67. PubMed ID: 21029471
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of the catechol-O-methyltransferase Val158Met genotype on the cognitive function of schizophrenia patients and healthy Japanese individuals.
Tsuchimine S; Yasui-Furukori N; Kaneda A; Kaneko S
PLoS One; 2013; 8(11):e76763. PubMed ID: 24282499
[TBL] [Abstract][Full Text] [Related]
3. Association study of the functional Catechol-O-Methyltranferase (COMT) Val
Khanthiyong B; Thanoi S; Reynolds GP; Nudmamud-Thanoi S
Int J Med Sci; 2019; 16(11):1461-1465. PubMed ID: 31673237
[TBL] [Abstract][Full Text] [Related]
4. Effects of transcranial direct current stimulation (tDCS) on executive functions: influence of COMT Val/Met polymorphism.
Plewnia C; Zwissler B; Längst I; Maurer B; Giel K; Krüger R
Cortex; 2013; 49(7):1801-7. PubMed ID: 23237479
[TBL] [Abstract][Full Text] [Related]
5. Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met/met genotype in methamphetamine-related executive dysfunction.
Cherner M; Watson CW; Saloner R; Halpin LE; Minassian A; Murray SS; Vaida F; Bousman C; Everall I;
Addict Behav; 2019 Nov; 98():106023. PubMed ID: 31301644
[TBL] [Abstract][Full Text] [Related]
6. COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in cannabis users.
Verdejo-García A; Fagundo AB; Cuenca A; Rodriguez J; Cuyás E; Langohr K; de Sola Llopis S; Civit E; Farré M; Peña-Casanova J; de la Torre R
Neuropsychopharmacology; 2013 Jul; 38(8):1598-606. PubMed ID: 23449176
[TBL] [Abstract][Full Text] [Related]
7. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
[TBL] [Abstract][Full Text] [Related]
8. Association study of a functional catechol-o-methyltransferase polymorphism and cognitive function in patients with dementia.
Nedić G; Borovecki F; Klepac N; Mubrin Z; Hajnsek S; Nikolac M; Muck-Seler D; Pivac N
Coll Antropol; 2011 Jan; 35 Suppl 1():79-84. PubMed ID: 21648315
[TBL] [Abstract][Full Text] [Related]
9. Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia.
Nkam I; Ramoz N; Breton F; Mallet J; Gorwood P; Dubertret C
PLoS One; 2017; 12(1):e0170147. PubMed ID: 28085950
[TBL] [Abstract][Full Text] [Related]
10. Association of Catechol-O-methyltransferase val/met polymorphism with cognitive function in Gilles de la Tourette syndrome patients.
Ji W; Li N; Ju K; Zheng H; Yang C; Xu P; Chen S; Cao A; Chen X; Guo L
Neurol Sci; 2015 Apr; 36(4):561-70. PubMed ID: 25367405
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.
Bilder RM; Volavka J; Czobor P; Malhotra AK; Kennedy JL; Ni X; Goldman RS; Hoptman MJ; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Kunz M; Chakos M; Cooper TB; Lieberman JA
Biol Psychiatry; 2002 Oct; 52(7):701-7. PubMed ID: 12372660
[TBL] [Abstract][Full Text] [Related]
12. Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults.
de Frias CM; Annerbrink K; Westberg L; Eriksson E; Adolfsson R; Nilsson LG
J Cogn Neurosci; 2005 Jul; 17(7):1018-25. PubMed ID: 16102234
[TBL] [Abstract][Full Text] [Related]
13. Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine.
Hamidovic A; Dlugos A; Palmer AA; de Wit H
Psychiatr Genet; 2010 Jun; 20(3):85-92. PubMed ID: 20414144
[TBL] [Abstract][Full Text] [Related]
14. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.
Goldberg TE; Egan MF; Gscheidle T; Coppola R; Weickert T; Kolachana BS; Goldman D; Weinberger DR
Arch Gen Psychiatry; 2003 Sep; 60(9):889-96. PubMed ID: 12963670
[TBL] [Abstract][Full Text] [Related]
15. Schizophrenia, cannabis use and Catechol-O-Methyltransferase (COMT): Modeling the interplay on cognition.
Bosia M; Buonocore M; Bechi M; Stere LM; Silvestri MP; Inguscio E; Spangaro M; Cocchi F; Bianchi L; Guglielmino C; Cavallaro R
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():363-368. PubMed ID: 30790675
[TBL] [Abstract][Full Text] [Related]
16. Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.
Haraldsson HM; Ettinger U; Magnusdottir BB; Sigmundsson T; Sigurdsson E; Ingason A; Petursson H
Schizophr Bull; 2010 Jan; 36(1):157-64. PubMed ID: 18562342
[TBL] [Abstract][Full Text] [Related]
17. The catechol-O-methyltransferase Val(158)Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: a PET study.
Wu K; O'Keeffe D; Politis M; O'Keeffe GC; Robbins TW; Bose SK; Brooks DJ; Piccini P; Barker RA
Brain; 2012 Aug; 135(Pt 8):2449-57. PubMed ID: 22843413
[TBL] [Abstract][Full Text] [Related]
18. Association between the catechol-O-methyltransferase (COMT) Val158Met polymorphism and manual aiming control in healthy subjects.
Lage GM; Miranda DM; Romano-Silva MA; Campos SB; Albuquerque MR; Corrêa H; Malloy-Diniz LF
PLoS One; 2014; 9(6):e99698. PubMed ID: 24956262
[TBL] [Abstract][Full Text] [Related]
19. Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders.
Ehlis AC; Reif A; Herrmann MJ; Lesch KP; Fallgatter AJ
Neuropsychopharmacology; 2007 Jan; 32(1):162-70. PubMed ID: 16823382
[TBL] [Abstract][Full Text] [Related]
20. Effect of schizotypy on cognitive performance and its tuning by COMT val158 met genotype variations in a large population of young men.
Smyrnis N; Avramopoulos D; Evdokimidis I; Stefanis CN; Tsekou H; Stefanis NC
Biol Psychiatry; 2007 Apr; 61(7):845-53. PubMed ID: 17123481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
